Pages: 1 2 | Single Page
Fidaxomicin May Be Best Choice for C. difficile
By David Douglas (Reuters Health)
|
on August 7, 2018
|
0 Comment
Topics: C. difficileFidaxomicininfectionQuality & Safety
Related
-
Tread Cautiously with Artificial Intelligence in Clinical Scenarios
July 8, 2024 - 0 Comment -
July 2024 News from the College
July 6, 2024 - 0 Comment -
June 2024 News from the College
June 11, 2024 - 0 Comment
No Responses to “Fidaxomicin May Be Best Choice for C. difficile”